OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Katy Beckermann: New Meta-Analysis Highlights the Importance of FGFR3 Testing

Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology Target?

OncoDaily Senior Vice President Shushan Hovsepyan Named Candidate for UICC Board of Directors 2026–2028

MATTERHORN: Durvalumab Plus FLOT Improves OS in Resectable Gastric and GEJ Adenocarcinoma

STAMINA Trial: Lifestyle Intervention Mitigates ADT-Associated Adverse Effects in Prostate Cancer

Oncology News, Insights, Stories by OncoDaily

Princess Dina Mired
Voices

HRH Princess Dina Mired: In Memoriam of My Dear Friend Navid Madani

ADAURA
Lung Oncology

ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

Daraxonrasib
Not To Miss

FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer

ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

Trump Administration Launches FDA Expedited IND Pilot to Speed First-in-Human Trials

Amol Akhade: Last day at WCLC 2026, King Keytruda survived?

HRH Princess Dina Mired: In Memoriam of My Dear Friend Navid Madani

FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer

Robert Lentz on Serial ctDNA: A Promising Shift From Detection to Treatment Decisions

Pavlos Msaouel: Rethinking Clinical Trial Design for Rare RCC Subtypes

Voices
Syed Ali Shazif Baqari

Syed Ali Shazif Baqari: What Cancer Treatment Does to a Child's Sense of Self?

T. Peter Kingham: Why and How to Improve Cancer Outcomes in Nigeria and Globally?

Ransom Onyema: Jessica-Mary’s Journey to Medical School in the UK

Sarah Sammons: Steroid Free Antiemetic Regimen in Phase III Trial

Eric K. Singhi: How Do We Choose as New Options Emerge for Patients With EGFR Exon 20 NSCLC?

Tom John: Mal Itchins Highlights First - Line ARROS1 Data in ROS1 Positive Lung Cancer

Why Strengthening the Cancer Care Pathway Is Critical to Improving Outcomes Across Africa - UICC

FDA Approvals
Bexlutry

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

EORTC Quality of Life Group Autumn Meeting 2026

EORTC Quality of Life Group

24 Sep
EORTC Quality of Life Group

Gynaecological Oncology and Colposcopy Surgical Workshop 2026

International Egyptian Representative Committee of the Royal College of Obstetricians and Gynaecologists

29 Nov
Colposcopy Surgical Workshop

AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer

American Association for Cancer Research (AACR)

06 Dec
AACR Special Conference

31st CTOS Annual Meeting 2026

Connective Tissue Oncology Society

18 Nov
CTOS

27th Annual IPOS World Congress

International Psycho-Oncology Society (IPOS)

09 Nov
IPOS

Immune-oncology
The Big Questions in Cancer Immunotherapy: Can We Predict Who Will Respond Before Treatment Starts?

The Big Questions in Cancer Immunotherapy: Can We Predict Who Will Respond Before Treatment Starts?

Cancer Immunotherapy: 2016 vs 2026

Can Oncolytic Viruses Make CAR-T-Cell Therapy More Adaptable in B-Cell Malignancies?

A New Model of PD-1 Inhibition: Unphosphorylated Tyrosines Block T-Cell Signaling Condensate Formation

Myeloid-Derived Suppressor Cells in Cancer: How MDSCs Block Immunotherapy

Can 3D Ex Vivo Lymphoma Spheroids Predict Immunotherapy Response? 

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Gastrointestinal-Oncology
MATTERHORN

MATTERHORN: Durvalumab Plus FLOT Improves OS in Resectable Gastric and GEJ Adenocarcinoma

10 Must-Read Posts In GI Oncology This Week

Phase 3 EMERALD-3 Trial: STRIDE ± Lenvatinib Plus TACE in Embolization-Eligible HCC

Why Gastric Cancer Spreads Across the Abdomen: The Biology of Peritoneal Metastasis

Can Pancreatic Cancer Be Detected Early? Symptoms, Biomarkers, and New Tests

Hepatocellular Carcinoma and Viral Hepatitis: How HBV and HCV Drive Liver Cancer

Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Breast-Oncology
BRCA-Mutated Early TNBC

BRCA-Mutated Early TNBC Shows Worse Outcomes Despite Adjuvant Capecitabine in Real-World Study

Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology Target?

SERENA-4 Misses Its Primary Endpoint: What the First-Line Camizestrant Result Means for HR-Positive Breast Cancer

SERENA-4 Phase III Trial Misses Primary PFS Endpoint for Camizestrant Plus Palbociclib in First-Line Advanced Breast Cancer

Breast Cancer ADC Trials 2026: Critical PFS–OS Gap Revealed

Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1

Anbenitamab Plus HB1801 Improves Pathologic Complete Response in HER2-Positive Early Breast Cancer

Lung-Oncology
ADAURA

ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target

Osimertinib Shows Sustained 8-Year Survival Benefit in Early-Stage EGFR-Mutated NSCLC in ADAURA

Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04

Tambotatug Pelitecan Improves Overall Survival in Relapsed Small-Cell Lung Cancer in Phase III TAISHAN-302 Trial

WCLC 2026 Opens in Seoul: Targeted Therapy Moves Earlier as SCLC Enters a New Therapeutic Era

DeLLphi-305: Durvalumab + Tarlatamab Improves Survival in First-Line ES-SCLC

OncoDaily TV
Lynda Chin

The Future is Near. Can We Finally Stop Cancer Resistance? Dr. Lynda Chin

AI

Can you trust AI with your CANCER? Shaalan Beg

Christian Ntizimira

Continue to be human: Christian Ntizimira

Stephanie Kauffman

She Left Hollywood To Fight Cancer: Stephanie Kauffman

pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Not To Miss
FDA

Trump Administration Launches FDA Expedited IND Pilot to Speed First-in-Human Trials

WHO Unveils 2026–2030 Strategy to Close the Childhood Cancer Medicines Gap

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

New "Value Cube" Framework in Nature Medicine Seeks to Redefine Value in Global Oncology

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 2

OncoGrants
Cancer Research Grant

Elsa U. Pardee Foundation Cancer Research Grant

Ovarian Cancer

Conquer Cancer Research Professorship in Ovarian Cancer 2027

Allied World–St. Baldrick’s Survivorship

Allied World–St. Baldrick’s Survivorship and Supportive Care Research Grant 2027

Career Development Award

St. Baldrick’s Scholar Career Development Award 2027

St. Baldrick’s Foundation Research

The St. Baldrick’s Foundation Research Grant Award 2027

Traditional Grant Program

Gateway for Cancer Research Traditional Grant Program 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Nataliya Kovalchuk

Nataliya Kovalchuk

Oncologists Location Stanford, USA
Guillermo Chantada

Guillermo Chantada

Oncologists Location Esplugues de Llobregat, USA
Florian Lordick

Florian Lordick

Oncologists Location Leipzig, Germany
Matti Aapro

Matti Aapro

Oncologists Location Genolier, Switzerland
Philip Philip

Philip Philip

Oncologists Location Detroit, USA
Aadhya Tiwari

Aadhya Tiwari

Oncologists Location Houston, USA
Rachna Shroff

Rachna Shroff

Oncologists Location Tucson, USA
Sara Tolaney

Sara Tolaney

Oncologists Location Boston, USA

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Bibek Aryal

Bibek Aryal: Introducing the Value Cube for Global Oncology

Enrique Grande

Enrique Grande: Rethinking Bladder Preservation in Muscle-Invasive Bladder Cancer

Salman Punekar

Salman Punekar: Daraxonrasib Marks a New Era for RAS-Mutated Lung Cancer

Sacrococcygeal Teratomas

New Paper Alert: Multidisciplinary Management of Altman Type III Sacrococcygeal Teratomas in Benin

Jithma Abeykoon

Jithma Abeykoon: NGS Profiling Is Essential for All Rosai-Dorfman Disease Tumors

Jasmin Hundal

Jasmin Hundal: New Study Reveals Breast Cancer Disparities Among South Asian American Women

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts